Germany· DE-A57-e40a561f0c13c81c
Lurasidon Elpen
A lurasidone product containing lurasidone, registered in Germany by Elpen Pharmaceutical Co. Inc.. The same ATC class is registered in 16 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Lurasidone is registered in 16 of 19 countries.
Countries holding a registration under ATC N05AE05 (lurasidone), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 9 of them publish a price we can compare per daily dose
Lurasidone · ATC N05AE05
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lurasidone costs, country by country.
Normalised to the WHO defined daily dose (60 mg), the median price runs from $2.63 in Italy to $6.45 in Switzerland — a ×2.4 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lurasidone · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- CH Switzerland$6.45
- IT Italy$2.63
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Lurasidone
- Manufacturer
- Elpen Pharmaceutical Co. Inc.
- Country
- Germany (DE)
- ATC code
- N05AE05
- ATC class
- Lurasidone
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
242 interactions on record for lurasidone.
Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lurasidone · interactions on record
242 records
- 32 severe
- 205 moderate
Most severe, free to view
- MetoclopramideA03FA01severe
- AprepitantA04AD12severe
- KetoconazoleH02CA03severe
- ErythromycinJ01FA01severe
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lurasidone in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesLatudaSumitomo Pharma America, Inc.
- CzechiaISAQExeltis Czech s.r.o., Praha
- CanadaAURO-LURASIDONEAURO PHARMA INC
- United KingdomLatuda 18.5mg tabletsDE Pharmaceuticals
- PolandAlurazenTarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- SwedenLatuda 18,5 mg Filmdragerad tablettAngelini Pharma S.p.A.
- SpainLATUDA 18,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAngelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.P.A. Enunciabile An
- ItalyLATUDAANGELINI S.P.A.
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Lurasidon G.L., Lurasidon Genericon
- Bulgaria · Lurasidone Accord, Луразидон Тева
- Czechia · Isaq, Lurasidon G.L. Pharma
- Denmark · Elgera, Lurasidone Accord
- Spain · Lurasidona Cinfa, Lurasidona Tecnigen
- Finland · Lurasidone Accord
- United Kingdom (Northern Ireland) · Lurasidone Accord Healthcare, Lurasidone Amarox
- Greece · Elgera, Latomno
- Croatia · Lurasidon Teva
- Iceland · Latuda
- Italy · Lurasidone Accord, Lurasidone Doc
- Liechtenstein · Latuda
- Netherlands · Lurasidon Teva
- Norway · Latuda, Lurasidone Accord
- Poland · Alurazen, Asil
- Portugal · Latomno, Lurasidona Farmoz
- Sweden · Lurasidon G.L. Pharma, Lurasidone Accord
- Slovenia · Lurasidon Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/18c01ba5-ba4a-4e63-a62e-01ed647f5583 GET /v1/drugs/18c01ba5-ba4a-4e63-a62e-01ed647f5583?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Lurasidone",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about lurasidone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.